跳至主要内容
临床试验/EUCTR2021-001708-14-SE
EUCTR2021-001708-14-SE进行中(未招募)1 期

Antibiotic Impregnated Bone Graft to reduce infection in revision hip replacement. The ABOGRAFT trial - ABOGRAFT

Region Östergötland0 个研究点目标入组 1,200 人开始时间: 2021年5月12日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
1,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • * Age = 18 years
  • * Hip arthroplasty requiring reoperation or revision with bone graft
  • * Willing to provide informed consent.
  • * For women of childbearing potential; a negative pregnancy test prior to reoperation.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 240
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 960

排除标准

  • * Patients with prosthetic joint infection as the reason for the reoperation
  • * Known allergies and contraindications for the use of vancomycin or tobramycin
  • * Mental inability, reluctance or language difficulties that according to investigator judgement, result in difficulty understanding the meaning of study participation
  • * Expected difficulties to complete 2-year follow-up
  • * Women of child bearing potential not using contraception
  • * Pregnant women
  • * Nursing women

研究者

相似试验